143 related articles for article (PubMed ID: 38158940)
1. [Inflammatory bowel diseases: Transformation of representations. A review].
Maev IV; Bakulin IG; Skalinskaya MI; Skazyvaeva EV
Ter Arkh; 2023 Dec; 95(12):1064-1074. PubMed ID: 38158940
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt.
Esmat S; El Nady M; Elfekki M; Elsherif Y; Naga M
World J Gastroenterol; 2014 Jan; 20(3):814-21. PubMed ID: 24574754
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
4. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
[TBL] [Abstract][Full Text] [Related]
5. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
Ott C; Takses A; Obermeier F; Schnoy E; Müller M
World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
[TBL] [Abstract][Full Text] [Related]
6. Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
Herzog D; Fournier N; Buehr P; Rueger V; Koller R; Heyland K; Nydegger A; Spalinger J; Schibli S; Petit LM; Braegger CP;
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):598-607. PubMed ID: 29360691
[TBL] [Abstract][Full Text] [Related]
7. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
9. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
11. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
[TBL] [Abstract][Full Text] [Related]
12. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
[TBL] [Abstract][Full Text] [Related]
13. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
[TBL] [Abstract][Full Text] [Related]
14. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.
Barreiro-de Acosta M; Molero A; Artime E; Díaz-Cerezo S; Lizán L; de Paz HD; Martín-Arranz MD
Adv Ther; 2023 May; 40(5):1975-2014. PubMed ID: 36928496
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
[TBL] [Abstract][Full Text] [Related]
18. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of inflammatory bowel disease.
Burisch J; Munkholm P
Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
[TBL] [Abstract][Full Text] [Related]
20. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Vosoghinia H; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Rayatpisheh M; Sima AR; Malekzadeh R
Inflamm Bowel Dis; 2022 Jul; 28(7):1004-1011. PubMed ID: 34417824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]